Ledger.Open graph →
SEC Form D · filed July 24, 2017

ACTINOBAC BIOMED, INC

Offering
$2.4M
Sold
$2.4M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
KENDALL PARK, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Peter Alff · KENDALL PARK, NJDirectorScott Kachlany · KENDALL PARK, NJDirectorBenjamin Belinka · KENDALL PARK, NJExec · DirectorJames Golubieski · KENDALL PARK, NJDirectorPeter Alff · Kendall Park, NJDirectorScott Kachlany · Kendall Park, NJDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗